ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,323.00
-0.04%
S&P ASX All Technology
3,880.20
0.04%
Brent Oil
73.545
0.97%
US Dollar vs AUD
1.53442
-0.08%
Bitcoin
98,066.28
3.93%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Antisense Therapeutics Limited (ANP) Share Price

Antisense Therapeutics Limited

Antisense Therapeutics Limited (ANP)

Anpario Plc
0.058
0.00
(0.00%)
Closed 22 November 4:00PM
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.058
Bid
0.057
Offer
0.06
Volume
0.00
0.00 Day's Range 0.00
0.052 52 Week Range 0.063
Market Cap
52.29M
Previous Close
0.058
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
901,545,000
Dividend Yield
-
PE Ratio
-5.30
Earnings Per Share (EPS)
-0.01
Revenue
2.35M
Net Profit
-11.92M

About Antisense Therapeutics Limited

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
www.antisense.com.au
Headquarters
Melbourne, Victoria, Aus
Founded
2000
Antisense Therapeutics Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker ANP. The last closing price for Antisense Therapeutics was AUD0.06. Over the last year, Antisense Therapeutics shares have traded in a share price range of AUD 0.052 to AUD 0.063.

Antisense Therapeutics currently has 901,545,000 shares in issue. The market capitalisation of Antisense Therapeutics is AUD52.29 million. Antisense Therapeutics has a price to earnings ratio (PE ratio) of -5.30.

Ask ADVFN Intelligence (AI)

ANP Latest News

More News

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins...

24 August 2022
GlobeNewswire Inc.

Antisense Therapeutics Announces a Poster Presentation on the Muscular Dystrophy Association Virtual Conference 2020 website

Antisense Therapeutics (ASX:ANP | US OTC:ATHJY), an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a...

11 June 2020
Business Wire

Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint and Exceed Expectations on Secondary Endpoints

Primary endpoint met with confirmation of drug’s safety and tolerability Strong effects on secondary endpoints on activity markers and disease progression Improvement or stabilisation across...

21 May 2020
Business Wire

Antisense Therapeutics Announces Appointment of US-based Consultant Medical Director

Clinician with deep experience in DMD drug development (ex-Sarepta Therapeutics Director) On the ground presence in the US to accelerate development activities Initial focus on engagement with...

27 February 2020
Business Wire

ATL1102 for MS - Phase II trial results published in the leading Medical Journal Neurology

ATL1102 for MS - Phase II trial results published in the leading Medical Journal Neurology PR Newswire TOORAK, Australia, Sept. 22, 2014 TOORAK, Australia, Sept. 22, 2014 /PRNewswire/...

22 September 2014
PR Newswire (US)

ATL1103 Phase II Trial - Successful Efficacy Results

ATL1103 Phase II Trial - Successful Efficacy Results - Primary efficacy endpoint met with a statistically significant reduction of sIGF-I levels of 26% at the 400mg/week dose (P<0.0001; highly...

03 September 2014
PR Newswire (US)

ATL1103 Acromegaly Phase II Trial Dosing Completed

ATL1103 Acromegaly Phase II Trial Dosing Completed -Primary efficacy results on track to be received by end of August 2014 PR Newswire TOORAK, Australia, July 29, 2014 TOORAK, Australia, July 29...

29 July 2014
PR Newswire (US)

ATL1102 for MS - Toxicology Study Main Findings

ATL1102 for MS - Toxicology Study Main Findings PR Newswire TOORAK, Australia, April 1, 2014 TOORAK, Australia, April 1, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP" or the...

02 April 2014
PR Newswire (US)

ATL1103 Acromegaly Phase II Trial Recruitment Completed

ATL1103 Acromegaly Phase II Trial Recruitment Completed - 24 patients now recruited into the trial - 16 patients have completed dosing - No treatment related patient withdrawals or serious...

22 March 2014
PR Newswire (US)

ATL1102 for Stem Cell Mobilisation Trial Commencement

ATL1102 for Stem Cell Mobilisation Trial Commencement PR Newswire TOORAK, Australia, March 17, 2014 TOORAK, Australia, March 17, 2014 /PRNewswire/ -- Antisense Therapeutics (ASX:ANP) is pleased...

18 March 2014
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
52-0.004-6.451612903230.0620.0630.0525775340.05591468DE
156-0.157-73.0232558140.2150.2150.056396160.10242218DE
260-0.032-35.55555555560.090.350.02912707500.13273661DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HIQOHitIQ Limited
AUD 0.022
(633.33%)
25k
ARDOArgent Minerals Ltd
AUD 0.003
(200.00%)
18.41M
IFGInFocus Group Holdings Ltd
AUD 0.038
(153.33%)
61.11M
ADNOCAndromeda Metals Limited
AUD 0.002
(100.00%)
5M
FNRFar Northern Resources Ltd
AUD 0.18
(71.43%)
142.69k
OECROrbital Corporation Limited
AUD 0.001
(-98.48%)
9
ADXOADX Energy Limited
AUD 0.011
(-63.33%)
875k
CDECodeifai Ltd
AUD 0.001
(-50.00%)
82.68M
CRIOCritica Ltd
AUD 0.001
(-50.00%)
5M
AGEOCAlligator Energy Limited
AUD 0.01
(-28.57%)
36k
SYASayona Mining Limited
AUD 0.034
(-10.53%)
96.47M
CDECodeifai Ltd
AUD 0.001
(-50.00%)
82.68M
88E88 Energy Limited
AUD 0.002
(33.33%)
79.47M
PENPeninsula Energy Ltd
AUD 0.0545
(-3.54%)
72.33M
LPDLepidico Ltd
AUD 0.002
(0.00%)
65.86M

Discussion

View Full Feed
1vman 1vman 1 minute ago
*****🟥🟥🟥 Wowzah ! Yes ! 50 billion share authorized here

PEE YEW stinky OTC pinky here

https://www.otcmarkets.com/stock/UBQU/security

ENOUGH SAID HUZZAH🤪 !!!
UBQU
JP313 JP313 1 minute ago
I truly hope they fine him & throw him under the jail
PIFR
Mikey Mikey 2 minutes ago
lol, we may see 100k in the next couple of days......an animal!
BTCUSD
Siriam Siriam 2 minutes ago
Down again....
CLHI
ProLiberty ProLiberty 2 minutes ago
110k share bid at $0.50 if anyone needs to sell for tax loss into that. When should we hear about the Nasdaq extension decision?
AMRN
Doc logic Doc logic 2 minutes ago
Jackxkr,

Don’t worry. As you probably know, the old British war saying is “stay calm and carry on” very much applies in this situation. MHRA seems to be showing their determination to catch up with the biggest and easiest part of their backlog and then exceed expectations once they
NWBO
just Scottie just Scottie 3 minutes ago
Hoping we get an answer of some sort tomorrow. A new website for the hahalolo invest is supposed to be operating
https://invest.hahalolo.com/
FBEC
luckydude777 luckydude777 3 minutes ago
Picking up more buyers. Should be at $.10+ soon.
XTIA
Investor2014 Investor2014 3 minutes ago
FOLM and FOMO time again? Bas, Georgejjl - any advise?
AVXL
Bountiful_Harvest Bountiful_Harvest 3 minutes ago
NVIDIA: Accounting Game of Shadows
Sherlock Dives into the 10Q

(Published by The Coastal Journal Nov 21, 2024)

“The world is full of obvious things which nobody by any chance ever observes.” – Sherlock Holmes.

Ladies and gentlemen, welcome to a fin
NVDA
capgain capgain 3 minutes ago
Could be, I'm just so sick of these whining demonrats and media that insist on ignoring the will of the people.
LowFloatLopes LowFloatLopes 3 minutes ago
Sounds like more of a Viagra than a steroid lol 
QUBT
Tree Tree 3 minutes ago
LOL!!!
peafunke peafunke 4 minutes ago
Yes.  And not sure why we aren't. Something is awry 
TPTW
1vman 1vman 4 minutes ago
*****🟥🟥🟥 WOW !!! Yes GNCP is on the expert market - massive just massive losses here

https://www.otcmarkets.com/stock/GNCP/overview

ENOUGH SAID
GNCP
StockDetective StockDetective 4 minutes ago
https://m.youtube.com/watch?v=2HLhSWUvqxU
XRPUSD
RichieBoy RichieBoy 4 minutes ago
I got the firm impression Digibriks software was currently owned by MTi OS. Did you ever claim that or did I read it somewhere...
AFFU
infamous infamous 4 minutes ago
omg, on the 10q just out, all you have to do is do a search for the word DEFAULT, and youll find tons of default loan situations.
its like they cant put one dollar of their business to clear these loans. and it would take like $15mil to clear them it seems IMO.
ILAL
Moneysign5 Moneysign5 5 minutes ago
If that were the case we'd be in EM, no?
TPTW
dinogreeves dinogreeves 5 minutes ago
Anything is possible with a gamma squeeze, but let them sort out the issues first, common sense tells me with the current shares intact, 200-300 billion market cap is achievable, with AI being fact of life.
SMCI
Budots Budots 5 minutes ago
$CBDW Strategic Expansion Through ISO Partnerships https://allcapresearch.com/f/1606-corp%E2%80%99s-strategy-to-lead-in-ai-driven-investor-relations
CBDW
Budots Budots 5 minutes ago
$CBDW Strategic Expansion Through ISO Partnerships https://allcapresearch.com/f/1606-corp%E2%80%99s-strategy-to-lead-in-ai-driven-investor-relations
CBDW
familyof5 familyof5 5 minutes ago
.0003's BIDS out number the .0004's ASK by a 3 to 1 ratio. That has been the trend pretty much since Monday. Eighty percent (80%) of the last two weeks volume has come by the way of shares being bought on the ASK at .0004. I don't see the sell side conviction at .0003 that it would take to breach th
VPER
manibiotech manibiotech 5 minutes ago
So it's not part of your job description . So you get paid only to pump but not to call out fudsters . You should negotiate better terms . 
NWBO

Your Recent History

ASX
ANP
Antisense Therapeutics
BIT
AT1
Invesco AT1 Capital Bond...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved